423 related articles for article (PubMed ID: 17522335)
1. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-mediated gene transfer into the canine brain in vivo.
Candolfi M; Kroeger KM; Pluhar GE; Bergeron J; Puntel M; Curtin JF; McNiel EA; Freese AB; Ohlfest JR; Moore P; Lowenstein PR; Castro MG
Neurosurgery; 2007 Jan; 60(1):167-77; discussion 178. PubMed ID: 17228266
[TBL] [Abstract][Full Text] [Related]
3. A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.
Puntel M; Muhammad AK; Candolfi M; Salem A; Yagiz K; Farrokhi C; Kroeger KM; Xiong W; Curtin JF; Liu C; Bondale NS; Lerner J; Pechnick RN; Palmer D; Ng P; Lowenstein PR; Castro MG
J Virol; 2010 Jun; 84(12):6007-17. PubMed ID: 20375153
[TBL] [Abstract][Full Text] [Related]
4. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses.
Xiong W; Goverdhana S; Sciascia SA; Candolfi M; Zirger JM; Barcia C; Curtin JF; King GD; Jaita G; Liu C; Kroeger K; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
J Virol; 2006 Jan; 80(1):27-37. PubMed ID: 16352528
[TBL] [Abstract][Full Text] [Related]
5. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
[TBL] [Abstract][Full Text] [Related]
6. Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.
Ali S; King GD; Curtin JF; Candolfi M; Xiong W; Liu C; Puntel M; Cheng Q; Prieto J; Ribas A; Kupiec-Weglinski J; van Rooijen N; Lassmann H; Lowenstein PR; Castro MG
Cancer Res; 2005 Aug; 65(16):7194-204. PubMed ID: 16103070
[TBL] [Abstract][Full Text] [Related]
7. Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.
Muhammad AK; Puntel M; Candolfi M; Salem A; Yagiz K; Farrokhi C; Kroeger KM; Xiong W; Curtin JF; Liu C; Lawrence K; Bondale NS; Lerner J; Baker GJ; Foulad D; Pechnick RN; Palmer D; Ng P; Lowenstein PR; Castro MG
Clin Pharmacol Ther; 2010 Aug; 88(2):204-13. PubMed ID: 20164833
[TBL] [Abstract][Full Text] [Related]
8. Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.
Puntel M; A K M GM; Farrokhi C; Vanderveen N; Paran C; Appelhans A; Kroeger KM; Salem A; Lacayo L; Pechnick RN; Kelson KR; Kaur S; Kennedy S; Palmer D; Ng P; Liu C; Krasinkiewicz J; Lowenstein PR; Castro MG
Toxicol Appl Pharmacol; 2013 May; 268(3):318-30. PubMed ID: 23403069
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a canine glioma cell line as related to established experimental brain tumor models.
Rainov NG; Koch S; Sena-Esteves M; Berens ME
J Neuropathol Exp Neurol; 2000 Jul; 59(7):607-13. PubMed ID: 10901232
[TBL] [Abstract][Full Text] [Related]
12. Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.
King GD; Muhammad AK; Curtin JF; Barcia C; Puntel M; Liu C; Honig SB; Candolfi M; Mondkar S; Lowenstein PR; Castro MG
Neuro Oncol; 2008 Feb; 10(1):19-31. PubMed ID: 18079358
[TBL] [Abstract][Full Text] [Related]
13. Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.
Xiong W; Candolfi M; Kroeger KM; Puntel M; Mondkar S; Larocque D; Liu C; Curtin JF; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2008 Feb; 16(2):343-51. PubMed ID: 18180781
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial.
Muhammad AK; Xiong W; Puntel M; Farrokhi C; Kroeger KM; Salem A; Lacayo L; Pechnick RN; Kelson KR; Palmer D; Ng P; Liu C; Lowenstein PR; Castro MG
Hum Gene Ther Methods; 2012 Aug; 23(4):271-84. PubMed ID: 22950971
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplastic anterior pituitaries.
Southgate TD; Windeatt S; Smith-Arica J; Gerdes CA; Perone MJ; Morris I; Davis JR; Klatzmann D; Löwenstein PR; Castro MG
Endocrinology; 2000 Sep; 141(9):3493-505. PubMed ID: 10965923
[TBL] [Abstract][Full Text] [Related]
16. Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.
King GD; Kroeger KM; Bresee CJ; Candolfi M; Liu C; Manalo CM; Muhammad AK; Pechnick RN; Lowenstein PR; Castro MG
Mol Ther; 2008 Apr; 16(4):682-90. PubMed ID: 18283279
[TBL] [Abstract][Full Text] [Related]
17. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
Ulasov IV; Tyler MA; Han Y; Glasgow JN; Lesniak MS
Hum Gene Ther; 2007 Feb; 18(2):118-29. PubMed ID: 17328684
[TBL] [Abstract][Full Text] [Related]
18. Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
Xiong W; Candolfi M; Liu C; Muhammad AK; Yagiz K; Puntel M; Moore PF; Avalos J; Young JD; Khan D; Donelson R; Pluhar GE; Ohlfest JR; Wawrowsky K; Lowenstein PR; Castro MG
PLoS One; 2010 Jun; 5(6):e11074. PubMed ID: 20552015
[TBL] [Abstract][Full Text] [Related]
19. Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.
Nanda D; de Jong M; Vogels R; Havenga M; Driesse M; Bakker W; Bijster M; Avezaat C; Cox P; Morin K; Naimi E; Knaus E; Wiebe L; Smitt PS
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):939-47. PubMed ID: 12212546
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model.
VanderVeen N; Raja N; Yi E; Appelman H; Ng P; Palmer D; Zamler D; Dzaman M; Lowenstein PR; Castro MG
Hum Gene Ther Methods; 2016 Jun; 27(3):98-111. PubMed ID: 27056322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]